Results 261 to 270 of about 20,344 (273)

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

PLoS ONE, 2011
Lynda F Bonewald, Gerald J Atkins
exaly  

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men

Journal of Bone and Mineral Research, 2011
Sundeep Khosla
exaly  

SOST/sclerostin, an osteocyte-derived negative regulator of bone formation

Cytokine and Growth Factor Reviews, 2005
Peter ten Dijke, Socrates E Papapoulos
exaly  

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Journal of Bone and Mineral Research, 2011
exaly  

Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes

Proceedings of the National Academy of Sciences of the United States of America, 2017
Priyanka Kushwaha, Ryan E Tomlinson, Hye Lim Noh   +2 more
exaly  

Sclerostin Vaccine Prevents Osteoporosis

Science Trends, 2018
openaire   +1 more source

Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling

Journal of Biological Chemistry, 2005
exaly  

In silico identification of sclerostin inhibitors

Molecular Diversity
Sepici Dinçel, Aylin, Erkoç, Şakir, Uludamar, Altay, Ergünol, Erdal, Sahra Setenay, Baran, Şimşek, Yusuf   +5 more
openaire   +2 more sources

Osteoporosetherapie – Sclerostin im Visier

Aktuelle Rheumatologie, 2014
openaire   +1 more source

A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density

Journal of Bone and Mineral Research, 2015
exaly